欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
PT/H/1270/002
药品名称
Cloreto de Potássio e Glucose Kabi
活性成分
Glucose monohydrate 55.0 mg
Potassium chloride 3.0 mg
剂型
Solution for infusion
上市许可持有人
Fresenius Kabi Pharma Portugal, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Belgium (BE)
Kaliumchloride 0.3% + Glucose 5% Fresenius Kabi oplossing voor infusie
Netherlands (NL)
Kaliumchloride 0.3% - Glucose 5% Fresenius Kabi, oplossing voor infusie
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
France (FR)
Spain (ES)
Poland (PL)
Latvia (LV)
Potassium Chloride/Glucose Fresenius 3 mg/50 mg/ml šķīdums infūzijām
Lithuania (LT)
Potassium chloride/Glucose Fresenius 3 mg/50 mg/ml infuzinis tirpalas
Estonia (EE)
POTASSIUM CHLORIDE/GLUCOSE FRESENIUS 3 MG/50 MG/ML
许可日期
2015/04/22
最近更新日期
2025/04/16
药物ATC编码
B05BB02 electrolytes with carbohydrates
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
labip_KCl 0_15_Glucose5_apr2015_clean
Date of last change:2024/09/06
Final Product Information
|
labip_KCl 0_3_Glucose5_apr2015_clean
Date of last change:2024/09/06
Final Product Information
|
labop_KCl 0_15_Glucose5_may2014
Date of last change:2024/09/06
Final Product Information
|
labop_KCl 0_3_Glucose5_may2014
Date of last change:2024/09/06
Final Product Information
|
palen_KCl 0 3_Glucose5_dec2014_clean
Date of last change:2024/09/06
Final Product Information
|
palen_KCl 0_15_Glucose5_dec2014_clean
Date of last change:2024/09/06
Final Product Information
|
smpcen_KCl 0_15_Glucose5_feb2015_clean
Date of last change:2024/09/06
Final Product Information
|
smpcen_KCl 0_3_Glucose5_feb2015_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase